Statin effects on the lipidome: Predicting statin usage and implications for cardiovascular risk prediction
Journal of Lipid Research · 2025-05 · 66 (5) · 100800
DOI: 10.1016/j.jlr.2025.100800 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Lipid Research, 2025-05. Verfasst von Changyu Yi und 27 weiteren Autor:innen. Beteiligte Einrichtung: Diabetes and Population Health, Baker Heart and Diabetes Institute, Melbourne, Australia; Baker Department of Cardiometabolic Health, Melbourne Unive…. Hauptthemen laut MEDLINE: Hydroxymethylglutaryl-CoA Reductase Inhibitors, Cardiovascular Diseases, Lipidomics. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NIMH NIH HHS, NHLBI NIH HHS.
Abstract (Originalsprache)
Statin therapy is a highly successful and cost-effective strategy for the prevention and treatment of cardiovascular diseases (CVD). Adjusting for statin usage is crucial when exploring the association of the lipidome with CVD to avoid erroneous conclusions. However, practical challenges arise in real-world scenarios due to the frequent absence of statin usage information. To address this limitation, we demonstrate that statin usage can be accurately predicted using lipidomic data. Using three large population datasets and a longitudinal clinical study, we show that lipidomic-based statin prediction models exhibit high prediction accuracy in external validation. Furthermore, we introduce a re-weighted model, designed to overcome a ubiquitous limitation of prediction models, namely the need for predictor alignment between training and target data. We demonstrated that the re-weighted models achieved comparable prediction accuracy to ad hoc models which use the aligned predictor between training and target data. This innovation holds promise for significantly enhancing the transferability of statin prediction and other 'omics prediction models, especially in situations where predictor alignment is incomplete. Our statin prediction model now allows for the inclusion of statin usage in lipidomic analyses of cohorts even where statin use is not available, improving the interpretability of the resulting analyses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Diabetes and Population Health, Baker Heart and Diabetes Institute, Melbourne, Australia; Baker Department of Cardiometabolic Health, Melbourne University, Melbourne, Australia; Baker Department of Cardiovascular Resear…
- Diabetes and Population Health, Baker Heart and Diabetes Institute, Melbourne, Australia; Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Australia.
- Diabetes and Population Health, Baker Heart and Diabetes Institute, Melbourne, Australia; Baker Department of Cardiometabolic Health, Melbourne University, Melbourne, Australia.
- Diabetes and Population Health, Baker Heart and Diabetes Institute, Melbourne, Australia.
- School of Medicine, University of Western Australia, Perth, Australia; Lipid Disorders Clinic, Department of Cardiology, Royal Perth Hospital, Perth, Australia.
- School of Medicine, University of Western Australia, Perth, Australia.
Förderung
- NIDDK NIH HHS
- NIMH NIH HHS
- NHLBI NIH HHS
- National Institutes of Health
- National Health and Medical Research Council
- State Government of Victoria
- Bristol-Myers Squibb
Zitieren
APA
Yi, C., Huynh, K., Schooneveldt, Y., Olshansky, G., Liang, A., Wang, T., Beyene, H. B., Dakic, A., Wu, J., Cinel, M., Mellett, N. A., Watts, G. F., Hung, J., Hui, J., Beilby, J., Curran, J. E., Blangero, J., Moses, E. K., Simes, J., …, & Meikle, P. J. (2025). Statin effects on the lipidome: Predicting statin usage and implications for cardiovascular risk prediction. Journal of Lipid Research, 66(5), 100800. https://doi.org/10.1016/j.jlr.2025.100800
Vancouver
Yi C, Huynh K, Schooneveldt Y, Olshansky G, Liang A, Wang T, et al. Statin effects on the lipidome: Predicting statin usage and implications for cardiovascular risk prediction. Journal of Lipid Research. 2025;66(5):100800. doi:10.1016/j.jlr.2025.100800
BibTeX
@article{Yi2025,
author = {Yi, Changyu and Huynh, Kevin and Schooneveldt, Yvette and Olshansky, Gavriel and Liang, Amy and Wang, Tingting and Beyene, Habtamu B and Dakic, Aleksandar and Wu, Jingqin and Cinel, Michelle and Mellett, Natalie A and Watts, Gerald F and Hung, Joseph and Hui, Jennie and Beilby, John and Curran, Joanne E and Blangero, John and Moses, Eric K and Simes, John and Tonkin, Andrew M and Kritharides, Leonard and Sullivan, David and LIPID Study Investigators, LIPID Study Investigators and Shaw, Jonathan E and Magliano, Dianna J and Salim, Agus and Giles, Corey and Meikle, Peter J},
title = {Statin effects on the lipidome: Predicting statin usage and implications for cardiovascular risk prediction},
journal = {Journal of Lipid Research},
year = {2025},
volume = {66},
number = {5},
pages = {100800},
doi = {10.1016/j.jlr.2025.100800}
}
EUVIMED